- Home
- OLOX vs CELZ Comparison
OLOX vs CELZ Comparison
Compare OLOX & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLOX | CELZ |
|---|---|---|
| Founded | 2007 | 1998 |
| Country | | |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 7.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OLOX | CELZ |
|---|---|---|
| Price | $0.89 | $1.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 519.8K | 43.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1,628.82 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.83 | $1.50 |
| 52 Week High | $96.00 | $6.90 |
Technical Indicators
Market Signals| Indicator | OLOX | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 31.86 | 47.80 |
| Support Level | $0.89 | $1.83 |
| Resistance Level | $1.15 | $1.98 |
| Average True Range (ATR) | 0.12 | 0.13 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 12.09 | 52.78 |
Price Performance
Historical ComparisonAbout OLOX Olenox Industries Inc. Common Stock
Olenox Industries Inc is an industrial holding company focused on acquiring, operating, and scaling businesses that provide engineered solutions across industrial, energy, and infrastructure markets. Through its subsidiaries, it delivers high-quality modular and containerized systems designed for rapid deployment and long-term performance.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.